The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Understanding Mounjaro Face and Facial Changes
"Mounjaro face" is a colloquial term used to describe potential facial changes some people experience whilst taking Mounjaro (tirzepatide), a prescription-only GLP-1 receptor agonist and GIP receptor medication used for weight management in the UK. gradual weight management can sometimes lead to loose skin, reduced facial volume, or changes in facial appearance. This guide explains what happens, why it occurs, and practical steps to manage it based on NHS and clinical evidence.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Weight Loss Affects Facial Appearance
When significant weight loss occurs, the face is often one of the first areas to show visible changes. The skin stretches during weight gain to accommodate increased volume, and when that volume decreases rapidly, the skin may not retract fully, particularly in people over 40 where skin elasticity naturally decreases. This can result in a sagging or hollowed appearance sometimes referred to colloquially as "Mounjaro face."
Why this happens with tirzepatide:
- Mounjaro can produce faster weight loss than traditional dieting — clinical trials showed average losses of 15–21% body weight
- gradual weight management means facial volume decreases faster than skin can adjust
- The effect is not unique to Mounjaro — any gradual weight management, including from other GLP-1 injections or bariatric surgery, can cause similar changes
- Individual factors like age, genetics, hydration, and sun exposure influence how noticeable these changes are
It's important to note that this is a cosmetic concern rather than a medical safety issue. Your GP can discuss individual risk factors during your assessment for Mounjaro treatment.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Managing Facial Changes During Weight Loss
Several evidence-based strategies may help minimise visible facial changes whilst losing weight on Mounjaro:
- Gradual weight loss: Slower loss allows skin time to adapt. If facial changes are a concern, discuss pacing with your prescriber — dose escalation can be managed carefully
- Hydration and nutrition: Adequate water intake and protein support skin health and collagen production. Aim for 6–8 glasses of water daily
- Skincare: Moisturisers, retinoids, and sun protection (SPF 30+) can improve skin elasticity and appearance
- Cosmetic options: Dermatologists can discuss non-surgical options like dermal fillers or skin-tightening treatments if significant loose skin develops
Your GP or dermatologist can provide personalised advice based on your age, skin type, and degree of weight loss. Remember that the health benefits of weight loss typically outweigh cosmetic concerns — losing 5–10% of body weight significantly reduces health risks including type 2 diabetes and cardiovascular disease.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is "Mounjaro face" a real medical side effect?
"Mounjaro face" is not a listed medical side effect in the official Mounjaro patient information. It's a colloquial term describing cosmetic changes from gradual weight management. These changes are common with any fast weight loss method, not unique to Mounjaro. They reflect normal skin response to decreased facial volume rather than a toxic or dangerous effect.
Will my face look hollowed if I take Mounjaro?
Not necessarily. Individual results vary based on age, genetics, how much weight you lose, and how quickly. Younger people with good skin elasticity may see minimal changes. Gradual weight loss and proper skincare can help minimise visible effects. Your prescriber can discuss individual risk factors during your clinical assessment.
Can I prevent facial changes whilst taking Mounjaro?
You can minimise them by staying well hydrated, maintaining good nutrition (especially protein), using quality skincare with retinoids and sunscreen, and discussing a gradual escalation plan with your prescriber if facial changes are a significant concern. Slower weight loss gives skin more time to adapt naturally.
What should I do if I'm concerned about facial changes?
Discuss your concerns with your GP or prescriber before starting Mounjaro. They can assess your individual risk based on age and skin type. If changes occur and cause distress, dermatologists offer non-surgical options like fillers or skin treatments. Remember that the health benefits of weight loss almost always outweigh cosmetic concerns.
Is this different from other weight loss injections like Wegovy?
No. Any gradual weight management — whether from Mounjaro (tirzepatide), Wegovy (semaglutide), other GLP-1 injections, or bariatric surgery — can cause similar facial changes. This reflects the normal physiology of rapid volume loss rather than a drug-specific effect. Your prescriber can explain what to expect based on your individual circumstances.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.